Hims & Hers Health

Ask Sterling

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving the EV sector growth?

Favorites

Revenue Breakdown

Revenue Flow

Balance Sheet

Q4 2019-Q2 2026(All available data)

Cash Flow

Q1 2019-Q2 2026(All available data)

Hims & Hers Health

Largest US telehealth distribution channel for GLP-1. Compounded semaglutide subsidiary being unwound under FDA bulk-substance crackdown; Novo Nordisk branded-distribution deal March 2026 for semaglutide injections and pills.

$HIMSSan Francisco, CA1,400hims.com

SectorsGLP-1

Frequently asked questions

What does Hims & Hers Health do?

Hims & Hers Health (HIMS) is a Health Information Services company. Largest US telehealth distribution channel for GLP-1. Compounded semaglutide subsidiary being unwound under FDA bulk-substance crackdown; Novo Nordisk branded-distribution deal March 2026 for semaglutide injections and pills. It was founded in 2017, is headquartered in San Francisco, CA and employs about 1,400 people.

How has Hims & Hers Health's revenue and profitability trended?

Track Hims & Hers Health's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated August 22, 2026.

Who are Hims & Hers Health's main competitors?

Sterling groups Hims & Hers Health in the GLP-1 sector, alongside McKesson (MCK), Cencora (COR), Cardinal Health (CAH) and CVS Health (CVS).

If I'm investing in Hims & Hers Health, what similar companies should I consider?

If you are researching Hims & Hers Health, also look at McKesson (MCK), Cencora (COR) and Cardinal Health (CAH). You can compare all of them side by side or browse the full GLP-1 sector on Sterling.